SEVERAL RISK FACTORS ASSOCIATED with an increased rate of progression in renal disease have been informed, including African-American race, male sex, hypertension, obesity, diabetes, hyperlipidemia, smoking, high-protein intake, phosphate retention, and metabolic acidosis (36) . Although obesity is often associated with diabetes and hypertension, which are two of the most common risk factors for the development of end-stage renal disease (ESRD), it has been suggested that obesity per se is an independent risk factor (22) . Massive obesity has been shown to produce nephrotic syndrome (56, 58) , and it has been reported that proteinuria and segmental glomerulosclerosis can be present in obese patients, even in the absence of diabetes (59) . In addition, a large-scale study including 6,818 renal biopsies from 1986 to 2000 revealed a 10-fold increase in renal lesion, such as glomerulomegaly and focal segmental glomerulosclerosis, which were associated with obesity. Increased frequency of obesity-related glomerulopathy over the studied time ran in parallel with the increased prevalence of obesity within general population (33) .
Mediators involved in obesity-induced renal injury are poorly understood. Available information comes from studies performed in rats and dogs fed with high-fat diet (23, 25) and from fatty Zucker rat (17, 31, 34, 38, 41, 49) , an animal model of genetic obesity that results from inactivating mutation in leptin receptor gene. Homozygous Zucker rats (fa/fa) exhibit most of the metabolic picture seen in human obesity, including hypercholesterolemia, hypertriglyceridemia, hyperinsulinemia, and proteinuria. These animals also develop glomerular hypertension, hypertrophy, and sclerosis (6, 17, 31, 49) and often die due to ESRD (31) . The mechanism by which renal disease is produced in obese Zucker rats is largely unknown, but it has been shown that consumption of plant-derived proteins retards the development and progression of renal disease in humans and in several animal models of disease (9, 27, 30, 46, 52, 61) . Maddox et al. (39) observed that soy protein diet reduces plasma cholesterol levels, urinary protein excretion, and the rate of progression of glomerular injury in obese Zucker rat. The mechanisms by which soy protein conferred renal protection, however, were not established, but it has been suggested that could be related to the high content of phytoestrogens in soybean products, compared with animal sources of protein (54) . Isoflavones (the most common phytoestrogens in soy plant) have been shown to possess antiproliferative and antioxidant properties (51, 57) and to act as weak estrogens (40) by blocking transcription of growth factor-␤ 1 (35) and by inhibiting activation of transcription factors such as nuclear factor-B and activator protein-1 (62, 63) .
A number of recent studies showed that nitric oxide (NO) synthesis is reduced in chronic renal disease in both humans and animals (2, 48, 55, 60) . Therefore, it has been suggested that an impaired NO synthetic pathway could have a key role in mediating the complex renal hemodynamic and nonhemodynamic mechanisms associated with the progression of renal disease (for a review, see Ref. 44) . In this regard, Frisbee and Stepp (16) informed that obese Zucker rats exhibit a considerable impairment of endothelium-dependent vasodilatation in skeletal muscle arterioles, raising the possibility that NO deficiency could contribute to progression of renal disease in this animal model. Caveolin-1, the resident integral membrane protein of caveolae, is upregulated in bovine aortic endothelial cells exposed to serum of hypercholesterolemic patients (12) , and several lines of evidence demonstrate that, by interacting with endothelial NO synthase (eNOS), caveolin-1 inhibits the activity of this enzyme (19, 20, 32) , thus reducing NO production. In addition, it is known that soy protein has a higher L-arginine content, the precursor of NO. Taking all this information together, we reasoned that one of the possible mechanisms by which soy diet confers renal protection in Zucker rats could be related to improvement of NO generation. Here, we show that renal protection conferred by soy protein diet in Zucker rats is associated with increase in NO metabolites excretion rate, changes in expression pattern of NO synthases, and reduction of caveolin-1 expression within the kidney.
MATERIALS AND METHODS
Twenty-four lean (Fa/Fa) and 40 obese (fa/fa) Zucker rats were obtained at 5 wk of age (Harlan, Indianapolis, IN) and randomly divided into four groups: lean and obese Zucker rats fed ad libitum with 20% casein protein, constituting Fa/Faϩcas and fa/faϩcas groups, respectively. The other two groups of lean and obese Zucker rats were fed with 20% soy protein, forming Fa/Faϩsoy and fa/ faϩsoy groups, respectively. Body weight and food intake were recorded every day. Rats were placed in metabolic cages every 30 days at 22°C with 12:12-h light-dark cycle and free access to water and thereafter were anesthetized with carbon dioxide and killed by decapitation. Obese rats were studied at 30, 60, 90, 120, and 160 days, whereas lean rats at 90, 120, and 160 days. All procedures followed were in accordance with our institutional guidelines.
Functional studies. Individual 24-h urine samples were collected by placing animals in metabolic cages. Urinary protein excretion was measured by TCA turbidimetric method (26) . Serum and urine creatinine concentration were measured with an autoanalyzer (Technicon RA-1000, Bayer, Tarrytown, NY), and renal creatinine clearance was calculated by the standard formula C ϭ U*V/P, where U is the concentration in urine, V is urine flow rate, and P is the plasma concentration. The end products of NO, nitrites, and nitrates (NO 2 Ϫ and NO 3 Ϫ ) were estimated in 24-h urine samples by reducing NO 3 Ϫ to NO 2 Ϫ using nitrate reductase (Roche) and ␤-adenine nicotinamide (␤-NADPH, Sigma), followed by nitrites quantification with the Griess reagent, as we and others previously reported (8, 43) .
Serum insulin was determined by RIA with rat insulin kit (Linco Research, St. Charles, MO). The sensitivity for rat insulin assay was 0.1 ng/ml, and the intra-and interassay coefficients of variation were Ͻ5 and Ͻ5%, respectively. Immune complexes were counted with cobra II gamma counter (Packard Instrument, Menden, CT). Serum cholesterol and tryglicerides were measured enzimatically according to the manufacturer's instructions (Lakeside Diagnostics).
RNA isolation. Total RNA was isolated from cortexes or medullas of each group following guanidine isothyocianate-cesium chloride method (47) . The integrity of isolated total RNA was examined by 1% agarose gel electrophoresis, and RNA concentration was determined by UV light absorbance at 260 nm (Beckman DU640, Brea, CA).
RT-PCR.
Relative level of NOS and caveolin mRNA expression was assessed in renal cortex and medulla by semiquantitative RT-PCR, as previously described (3, 4) . Briefly, all primer sequences were custom obtained from GIBCO BRL (Gaithersburg, MD). Sense nNOS primers were 5Ј-GAACCCCCAAGACCATCC-3Ј and antisense 3Ј-GGCTTTGCTCCCACAGTT-5Ј, which amplified a fragment of 308 bp, bases 692 to 999 (3); sense inducible (i)NOS primers were 5Ј-GTG TTC CAC CAG GAG ATG TTG-3Ј and antisense 5Ј-CTC CTG CCC ACT GAG TTC GTC-3Ј, which amplified a fragment of 570 bp, bases 1407 to 1977 (42) ; sense eNOS primers were 5Ј-CCG GAA ATT CGA ATA CCA GCC TGA TCC ATG GAA-3Ј and antisense 5Ј-GCC GGA TCC TCC AGG AGG GTG TCC ACC GCA TG-3Ј, which amplified a fragment of 614 bp, base 2456 to 3069 (1), and caveolin-1 sense primers were 5Ј-ATG TCT GGG GGT AAA TAC GT-3Ј and antisense: 5Ј-CCT TCT GGT TCC GCA ATC AC-3Ј, which amplified a fragment of 230 bp, bases 1 to 230 (50) . To evaluate or reduce nonspecific effects of experimental treatment and to semiquantify NOS isoforms or cavelin-1 expression, we amplified a fragment of GAPDH, using primers previously described (3). Genomic DNA contamination was checked by treating all RNA samples with DNAase and by carrying samples through PCR procedure without adding reverse transcriptase.
RT was carried out using 2.5 g of total RNA from renal cortexes or medullas. Before RT reaction, total RNA was heated at 65°C for 10 min. RT was performed at 37°C for 60 min in a total volume of 20 l using 200 U of the Moloney murine leukemia virus reverse transcriptase (GIBCO BRL), 100 pmol of random hexamers (GIBCO BRL), 0.5 mM of each dNTP (Sigma, St. Louis, MO), and 1ϫ RT buffer (75 mM KCl, 50 mM Tris ⅐ HCl, 3 mM MgCl 2, 10 mM DTT, pH 8.3). Samples were heated at 95°C for 5 min to inactivate the reverse transcriptase and diluted to 40 l with PCR grade water. One-tenth of RT individual samples of each group was used for each NOS isoform or GAPDH amplification in 20-l final volume reactions containing 1ϫ PCR buffer (10 mM Tris ⅐ HCl, 1.5 mM MgCl 2, 50 mM KCl, pH 8.3), 0.1 mM of each dNTP, 0.2 Ci of [␣ 32 P]-dCTP (ϳ3,000 Ci/mmol, 9.25 MBq, 250 Ci), 10 M of each primer, and one unit of Taq DNA polymerase (GIBCO, BRL). Samples were overlaid with 30 l of mineral oil and PCR cycles were performed in a DNA thermal cycler (M.J. Research, Watertown, MA), with the following profile: denaturation 1 min at 94°C; annealing 1 min at 55°C for nNOS, iNOS, and caveolin, 58°C for eNOS primers; and 1 min extension step at 72°C. Last cycle was followed by a final extension step of 5 min at 72°C. Control gene was coamplified simultaneously in each reaction.
Amplification kinetics were performed following our standard procedure (3) (4) (5) 11) . To analyze PCR products, one-half of each reaction was electrophoresed in a 5% acrylamide gel. Bands were ethidium bromide stained and visualized under UV light, cut out, suspended in 1 ml of scintillation cocktail (Ecolume, ICN, Aurora, OH), and counted by liquid scintillation (Beckman LS6500, Fullerton, CA). The amount of radioactivity recovered from the excised bands was plotted in a log scale against the number of cycles. To semiquantify each NOS isoform, caveolin, and the control gene, all reactions were performed at least by quadruplicate.
Western blot analysis. Plasma membrane proteins from pooled renal cortexes or medullas were isolated by homogenization in sucrose buffer (0.32 M sucrose, 5 mM Tris ⅐ HCl, pH 7.5, 2 mM EDTA).
Homogenates were centrifuged at 3,000 g, supernatants were then centrifuged at 20,000 g, and final supernatants were centrifuged at 100,000 g. Each pellet was resuspended in a buffer containing 5 mM Tris ⅐ HCl (pH 7.5) and 2 mM EDTA. For nNOS detection, total proteins were also extracted from pooled cortexes or medullas by homogenization in four volumes of lysis buffer (225 mM mannitol, 75 mM sucrose, 0.1 mM EDTA, pH 7.0; 0.5 mM MOPS, pH 7.0, containing 5 mM benzamidine and 5 mM DTT). Homogenates were centrifuged at 4,000 g for 4 min at 4°C to remove tissue debris without precipitating plasma membrane fragments. Protein concentrations were assessed in duplicate using Bio-Rad DC Protein assay (Bio-Rad, Hercules, CA). Protein samples containing 70 g of total protein or 50 g of plasma membrane proteins in 10 l loading buffer (6% SDS, 15% glycerol, 150 mM Tris, 3% bromophenol blue, 2% ␤-mercaptoethanol, pH 7.6) were resolved by SDS-PAGE, semidried, and electroblotted onto polyvinylidene difluoride membranes (Bio-Rad). Thereafter, membranes were cut and the lower part was incubated with a rabbit caveolin-1 antibody 1:500 (Abcam, Lexington, KY) overnight at 4°C, whereas the upper membrane was incubated with a goat actin antibody 1:2,500 (Santa Cruz Biotechnology, Santa Barbara, CA). Additional membranes containing total proteins or plasma membrane proteins were also incubated with rabbit nNOS polyclonal antibody 1:500 (Cayman Chemical, Ann Harbor, MI) and monoclonal eNOS antibody 1:250 (Zymed Laboratories, San Francisco, CA), respectively. Thereafter, membranes were washed three times for 30 min with TBS-T. For caveolin and nNOS detection, each membrane was incubated with the secondary antibody AP-conjugated goat antirabbit IgG 1:2,500 (Bio-Rad) for 60 min at 37°C and washed again. For eNOS detection, membranes were incubated with a secondary antibody AP-conjugated goat anti-mouse IgG 1:3,000 (Bio-Rad) for 60 min at 37°C and washed again. Whereas for actin detection, membranes were incubated with a secondary antibody donkey antigoat IgG-HRP (Santa Cruz Biotechnology). Proteins were detected by using an enhanced chemiluminescence kit (Bio-Rad) and autoradiography, following the manufacturer's recommendations. Bands were scanned for densitometric analysis.
Histological studies. Before renal cortex and medulla separation, one-half of the left kidney was taken and fixed in formalin-phosphate buffer for light microcopy studies. After appropriate dehydration, kidney slices were embedded in paraffin, sectioned at 3 m, and periodic acid-Schiff (PAS), eosin-hematoxilin, and trichromic stains were performed. Focal and global glomeruloesclerosis as well as extracapillar proliferation were counted in at least 150 glomeruli. Tubular atrophy and dilation were evaluated in ϳ300 tubules. The degree of tubulointerstitial fibrosis was evaluated by morphometry as we previously reported (11) . For this purpose, 10 subcortical periglomerular fields per Masson-stained section (magnification ϫ200) were randomly selected in kidneys from the different groups. The images were recorded, and the affected areas were delimited and semiquantified using Leica processing and analysis system (Leica Imaging System, Cambridge, UK). Finally, the proportion of fibrosis was calculated dividing the interstitial fibrosis by total area per field excluding the luminal tubular area. The histological analysis was performed without knowing the group at which each kidney belonged.
Statistical analysis. Comparison among the groups for continuous data was made by using ANOVA. When ANOVA showed a statistically significant difference, a group-by-group comparison was performed using a t-test with a Bonferroni's correction for multiple comparisons.
RESULTS
Physiological parameters of the four groups of Zucker rats at the end of the study are presented in Table 1 . As expected, body weight in obese rats was significantly elevated compared with that in lean controls. At the end of the study, obese rats fed with casein protein diet gained significantly less weight than rats fed with soy probably due to their physical deterioration. Kidney weight was also higher in obese rats compared with lean rats. The obese rats fed with soy (fa/faϩsoy) appeared to have less renal hypertrophy than fa/faϩcas group, given their significantly lower kidney weights. This difference remained significant when kidney/body weight ratio was calculated: the ratio in fa/faϩcas vs. fa/faϩsoy was 0.42 Ϯ 0.07 and 0.23 Ϯ 0.01 g/100 g body wt, respectively. Obese rats developed hypercholesterolemia, hypertriglyceridemia, and hyperinsulinemia compared with lean controls. Whereas in obese soyfeeding rats, cholesterol and tryglicerides serum levels were significantly lower than fa/faϩcas, without changes in insulin serum levels, confirming hypolipidemic effect of soy diet. Figure 1 shows urinary protein excretion and creatinine clearance in lean and obese rats fed with casein or soy diet along the study. No differences in urinary protein excretion were observed in lean rats during the period of the study, which remained within normal values (Fig. 1A) . In contrast, a significant progressive increase in proteinuria was observed in fa/ faϩcas group throughout the study. Abnormal urinary protein excretion began at day 60, at which the average value was 70.9 Ϯ 7.8 mg/24 h and at the end of the study proteinuria in this group was 280.5 Ϯ 83.6 mg/24 h. Interestingly, soy protein intake was associated with a significant reduction in proteinuria levels in obese rats, because at the day 60, average value was 25.0 Ϯ 8.0 mg/24 h and at day 160, the value was 92.8 Ϯ 39.4 mg/24 h. These differences were statistically significant compared with fa/faϩcas group. As shown in Fig. 1B , creatinine clearance in obese rats tended to be lower than control animals, but the difference was less evident in those rats fed with soy protein. Because at 160 days obese rats fed with casein had lesser body weight than soy animals, creatinine clearance was corrected by considering body weight of each animal. Glomerular filtration rate per 100 g of body weight in Fa/Faϩcas and Fa/Faϩsoy was 0.26 Ϯ 0.01 and 0.34 Ϯ 0.02 ml⅐min Ϫ1 ⅐100 g Ϫ1 (P ϭ 0.06), respectively, and in fa/faϩcas and fa/faϩsoy was 0.04 Ϯ 0.02 and 0.11 Ϯ 0.02 ml⅐min Ϫ1 ⅐100 g Ϫ1 (P ϭ 0.03), respectively. Although creatinine clearance in fa/faϩsoy was not completely normalized at the end of the study, a soy protective effect was clearly observed in this group, when it was compared with fa/faϩcas group. Figure 2 shows the quantification of the most important lesions observed in fatty Zucker rats, and representative images are shown in Fig. 3 . Fatty Zucker rats fed with casein exhibited the characteristic renal histological picture of this model that is segmental glomerulosclerosis, tubular dilation and atrophy, cast formation, and tubulointerstitial fibrosis. In fa/faϩcas group, percentage of glomerulosclerosis, tubular dilation, and tubulointerstitial fibrosis was 33.0 Ϯ 11.8, Fig. 2 . Renal histological alterations in fatty Zucker rats after 160 days of feeding with casein (open bars) or soy diet (solid bars). Glomerulosclerosis (A) and extracapillar proliferation percentage (D) were calculated from at least 150 observed glomeruli, whereas tubular dilation percentage (B) was obtained from 300 examined tubules. Finally, the percentage of fibrosis (C) was calculated dividing the interstitial fibrosis by total area from 10 fields per Masson stained. *P Ͻ 0.05 vs. fa/faϩcas. Fig. 3 . Representative renal light microscopic findings of fatty Zucker rats after 160 days that were fed with casein or soy protein diet. Kidney slides were stained with periodic acid-Schiff, showing greater focal glomerulosclerosis and tubular dilation in fa/faϩcas (A) than fa/faϩsoy (B) group (magnification ϫ100). Also, tubulointerstitial fibrosis (C) and extracapillar proliferation (D) were more prominent in fa/faϩcas than fa/faϩsoy group (Masson stain ϫ200).
14.7 Ϯ 9.8, and 10 Ϯ 1.9%, respectively. All structural changes observed in obese rats were significantly reduced by soy protein diet. In fa/faϩsoy group, mean percentage value of glomerulosclerosis, tubular dilation, and tubulointerstitial fibrosis were 8.3 Ϯ 5.8, 2.5 Ϯ 1.1, and 4.6 Ϯ 0.5, respectively. Thus our results indicate that the consumption of soy diet by obese Zucker rats reduces structural and functional changes.
To characterize the soy-protective effect on NO synthesis, end NO metabolites were quantified in urine. Urinary nitrites and nitrates excretion (UNO 2 /NO 3 V) is shown in Fig. 4 in lean and obese Zucker rats at 160 days after feeding with casein or soy protein diets. In lean Zucker rats, soy feeding had no effect on end NO metabolites excretion. In contrast, fa/faϩcas rats exhibited a significant reduction in UNO 3 /NO 2 V. Mean value was 238 Ϯ 77 nM/24 h in fa/faϩcas group vs. 3,114 Ϯ 702 nM/24 h in Fa/Faϩcas (P Ͻ 0.004); however, the reduction observed in UNO 3 /NO 2 V in fa/faϩcas rats was restored by soy protein intake, because average excretion in fa/faϩsoy group was 1,615 Ϯ 456 nM/24 h, a value that is significantly higher to that observed in fa/faϩcas group.
To explore if soy-induced renal protection is related to changes in intrarenal expression of NOS, neuronal (n)NOS and eNOS mRNA and protein levels were evaluated by semiquantitative RT-PCR and Western blot analysis, respectively (Figs. 5 and 6). Figure 5 , left, shows that in renal cortex, soy protein diet in lean rats did not produce changes in eNOS or nNOS mRNA levels compared with rats fed with casein. In contrast, cortical nNOS mRNA level was upregulated in obese rats fed with casein, an effect that was reverted in fa/faϩsoy group, together with a significant increase of eNOS expression in renal cortex. As shown in Fig. 5 , right, eNOS mRNA in medulla was downregulated in fa/faϩcas rats, whereas soy protein was associated with a significant increase of eNOS in both lean and obese animals. No changes in medulla nNOS mRNA levels among all groups were observed.
Western blotting was used to assess protein expression of these enzymes. Actin was used as control protein to normalize each sample. Figure 6 shows the abundance of eNOS in plasma membrane proteins extracted from renal cortex (A) and medulla (B). Figure 6 , top insets, are representative images of eNOS immunoblot. The eNOS protein level was similar in lean rats fed with casein or soy protein diet. In contrast, in fa/ faϩcas group, there was a significant increase by threefold of eNOS in plasma membrane proteins from renal cortex; this effect was not observed in the medulla. As expected, nNOS was not detected in membrane proteins fraction (data not shown); thus total proteins were used to analyze nNOS expression. No difference in cortical nNOS expression was observed in lean and obese rats, regardless the source of protein; how- ever, an increase in medulla nNOS protein was observed in fa/faϩcas compared with Fa/Faϩcas group (1.8 Ϯ 0.2 vs. 0.8 Ϯ 0.1, respectively), effect that was abrogated when rats were fed with soy diet (1.0 Ϯ 0.1; data not shown).
Because it is known that eNOS activity is modulated by caveollin-1, level of expression of this protein was evaluated in renal cortex and medulla. As shown in Fig. 7 , in renal cortex Fa/Faϩcas and Fa/Faϩsoy groups exhibited similar caveolin-1 mRNA levels. Caveolin-1/GAPDH ratio was 1.45 Ϯ 0.10 and 1.25 Ϯ 0.18, respectively. In contrast, fa/faϩcas group was associated with a significant caveollin-1 upregulation by almost twofold (2.60 Ϯ 0.33, P ϭ 0.008 vs. Fa/Faϩcas). Intriguingly, soy protein intake in obese rats prevented this upregulation, because caveolin-1/GAPDH ratio was 1.33 Ϯ 0.08 (P ϭ 0.004). In renal medulla, similar results were observed. Casein-fed obese Zucker rats had higher caveollin-1 mRNA level than lean rats fed with casein: 2.29 Ϯ 0.32 vs. 1.04 Ϯ 0.04, respectively (P Ͻ 0.005). This effect was prevented by soy protein diet, because the value in fa/faϩsoy group was 1.39 Ϯ 0.05. In addition, caveolin-1 protein levels were assayed in plasma membrane proteins obtained from rat renal cortex and medulla by using Western blot analysis (Fig. 8) . Western blot analysis confirmed our findings at mRNA level, caveolin-1 protein in isolated plasma membranes from renal cortex was significantly higher in fa/faϩcas that Fa/Faϩcas rats and the increase of these protein was normalized when rats were fed with soy protein diet (fa/faϩsoy group). A similar pattern was observed in renal medulla; however, the difference did not reach statistical significance.
DISCUSSION
In the present study, we observed that obese Zucker rats fed with casein developed a progressive renal disease characterized by proteinuria and glomeruloesclerosis that were associated with hypercholesterolemia, hypertrygliceridemia, and hyperinsulinemia. Renal progressive disease, as well as the increase in cholesterol and triglycerides levels, was significantly ameliorated when the obese Zucker rats were fed with soy instead casein protein diet. These observations are consistent with a previous report (39) , but little is known about the mechanism of the renal soy-protective effect. In this regard, hypertension seems not to be responsible for renal damage in this animal model, because Maddox et al. (39) observed that fatty Zucker rats exhibited only a slight increase in systolic blood pressure that cannot explain the development and progression of renal disease. Moreover, arterial pressure was not modified when rats were fed with soy. Data from this study revealed that soy diet conferring renal protection is associated with restoration of NO production.
A number of recent studies showed that NO synthesis is reduced in chronic renal disease in both humans and animals Fig. 6 . Inactive form of eNOS protein was assessed by Western blot analysis in proteins isolated from renal cortex plasma membrane (A) and medulla (B) in lean and obese Zucker rats. Insets: representative images of eNOS and actin immunoblot. Charts represent optical density ratio between eNOS and actin. Open bars correspond to rats fed with casein and solid bars correspond to rats fed with soy. *P Ͻ 0.05 vs. all groups. (2, 48, 55, 60) , suggesting that availability of NO in kidney is an important factor in defining the rate of progression injury in renal disorders. To explore the role of NO in renal protection conferred by soy protein diet, we evaluated the expression pattern of nNOS and eNOS in renal cortex and medulla, as well as NO metabolites excretion. We observed that both nNOS and eNOS expression pattern in obese rats fed with casein (fa/ faϩcas) was different to that observed in lean animals fed with the same diet. At mRNA levels, there was an upregulation of nNOS in cortex and a downregulation of eNOS in medulla, these changes were normalized by soy diet. At protein level, fa/faϩcas group presented a significant increase of nNOS in total proteins from renal medulla. Physiological significance of this observation is unclear because the role of nNOS in renal medulla is unknown. However, upregulation of nNOS was prevented in obese rats fed with soy diet. Interestingly, fa/ faϩcas group had a greater amount of eNOS in membrane proteins fraction, an effect that was also reverted in fa/faϩsoy rats. Although eNOS expression was higher in fa/faϩcas group, it is unlikely that eNOS in this animal model is active because most of this enzyme was located in plasma membrane, a location in which it is known that association with caveolin-1 precludes its activity. In addition to these findings, we observed an unexpected small, but significant, increase in caveolin-1 mRNA and protein expression in renal medulla from lean animals fed with soy. Because the physiological role of caveolin-1 in renal medulla is not known, interpretation of this finding is difficult. Interestingly, a recent study demonstrated that caveolin-1 knockout mouse develops hypercalciuria and urolithiasis, suggesting that caveolin-1 is a critical determinant of urinary calcium homeostasis (7) .
Supporting that changes in the NO synthetic pathway are altered in the fatty Zucker rats and that it is corrected by soy diet, we found that NO 2 Ϫ /NO 3 Ϫ urinary excretion in fa/faϩcas rats was considerably depressed and soy protein intake was associated with restoration of NO systemic production. In addition, recent studies showed that obese Zucker strain has an impairment in NO-mediated dilation of skeletal muscle arterioles, suggesting a deficient NO availability (16a, 24) .
NO biosynthesis is tightly regulated by a variety of mechanisms ranging from transcriptional to posttranslational level (37) . Recent studies indicate that some proteins directly interact with NOS-forming complexes that regulate NOS activity or spatial distribution in the cell. For instance, eNOS is regulated by proteins residing in or recruited to plasmalemmal caveolae of endothelial cells. Caveolins, the resident scaffolding proteins of caveolae, and calmodulin undergo reciprocal Ca 2ϩ -dependent association and dissociation with eNOS in the caveolar membrane that inhibits (caveolins) and activates (calmodulin) eNOS activity (10, 13, 21, 32) . Thus it has been suggested that association of eNOS to the caveolae through caveolin-1 maintains eNOS in its inactive form; on the contrary, the release of eNOS from caveolae is thought to facilitate the synthesis of NO (13, 21, 32) . In support to this, it has been demonstrated that the mice with targeted disruption of caveolin-1 exhibit enhanced eNOS activity (10) . Given the caveolin importance in regulating NO generation, we evaluated the expression of this protein. We observed that in normal lean rats, caveolin-1 is more abundant in medulla than in cortex plasma membrane proteins and that caveolin-1 mRNA and protein levels were significantly upregulated in cortex and medulla of fatty Zucker rats fed with casein, suggesting that increased expression of caveolin-1, together with greater amount of eNOS in plasma membrane, further decreases NO production in renal tissue. An interesting observation of this study is that soy protein diet significantly reduced caveolin-1 expression and eNOS abundance in plasma membranes in the kidney of these animals, suggesting that another mechanism by which soy diet improves NO generation is by decreasing the expression of caveolin-1, a natural inhibitor of NO synthesis (10, 13, 18, 21) .
Several studies in humans and animals have revealed that soy protein intake ameliorates proteinuria and progression of renal disease (9, 27, 30, 39, 46, 52, 53, 61 ). There are several possible mechanisms to explain this effect of soy. 1) Isoflavones. A component of soy that is believed to be involved in this protective effect is the isoflavones, by mechanisms that are still unclear, but include the following possibilities. Isoflavones comprise the most common class of phytoestrogens present mainly in soybean products. After ingestion, isoflavones are hydrolyzed in the intestine by bacterial ␤-glucosidases and converted to the bioactive aglicones: genistein and daidzein. Because isoflavones possess an important hypocholoresterolemic effect observed in this study (Table 1) , this is one of the mechanisms that have been suggested to be involved in renal protection induced by these compounds (34, 39, 46) . Renoprotection also could result from antioxidant properties of isoflavones, which not only could avoid formation of free radicals (45) but also might result in enhancing NO availability (29) . Finally, preliminary evidence suggests that diadzein directly downregulates caveolin-1 protein expression in rat aorta, which in turn was associated with twofold increase in NO metabolites (61a). 2) Amino acid content in soy protein.
Although both soy and casein protein sources contain the same amount of total amino acids, there are differences in the proportion of certain residues. For instance, L-arginine, precursor of NO, is more abundant in soy than in casein protein (7.6 vs. 3.7%, respectively) and glycine, another residue that has been shown to produce vasodilation (28) , is also more abundant in soy protein (4.2 vs. 1.8%, respectively). Therefore, soy-fed rats received a greater proportion of two residues that could be directly involved in vasodilatory processes. 3) Soyinduced hypocholesterolemia. It is possible that caveolin-1 downregulation results from hypocholesterolemic effect of soy diet, because Fielding and Fielding (15) postulated that caveolae behave as sensors of free cholesterol content of the cell and that depletion of caveolar cholesterol leads to downregulation of caveolin-1 at mRNA and protein levels (14) . Moreover, Feron et al. (12) observed that exposure of bovine endothelial cells to serum from hypercholesterolemic patients resulted in upregulation of caveolin-1, an effect that was associated with an impairment of basal NO release, together with an increase in formation of inhibitory caveolin-eNOS complex; thus these studies suggest that cholesterol level regulates caveolin-1 expression.
In summary, our data show that nephropathy associated with obesity in the obese Zucker rat model could be reduced by feeding animals with soy, instead casein protein diet. The protective effect of soy diet was associated with reduction in cholesterol and triglyceride levels, as well as correction of a marked reduction in NO generation, that was associated with restoration of a normal pattern of NOS expression in the kidney and reduction of eNOS, together with a downregulation of caveolin-1 in plasma membrane proteins. 
